2020
DOI: 10.1016/j.talanta.2020.121386
|View full text |Cite
|
Sign up to set email alerts
|

Measurement uncertainty evaluation from correlated validation data: Determination of elemental impurities in pharmaceutical products by ICP-MS

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 15 publications
(1 citation statement)
references
References 15 publications
0
1
0
Order By: Relevance
“…Measurement uncertainty associated with ciprofloxacin and acyclovir content was evaluated using bottom-up and/or top-down approaches (Separovic et al, 2023;Ellison, 2005;Milde et al, 2020;Morgado et al, 2021;Morgado et al, 2022;Pluháček et al, 2023). For the top-down approach, two main sources of uncertainty were considered: 1) the trueness component assessed as the mean recovery of samples with known concentrations of ciprofloxacin and acyclovir; and 2) the precision component assessed as the standard deviation of samples analyzed in repeatability conditions (Separovic et al, 2018;Separovic et al, 2023;Milde et al, 2020).…”
Section: Measurement Uncertainty Evaluationmentioning
confidence: 99%
“…Measurement uncertainty associated with ciprofloxacin and acyclovir content was evaluated using bottom-up and/or top-down approaches (Separovic et al, 2023;Ellison, 2005;Milde et al, 2020;Morgado et al, 2021;Morgado et al, 2022;Pluháček et al, 2023). For the top-down approach, two main sources of uncertainty were considered: 1) the trueness component assessed as the mean recovery of samples with known concentrations of ciprofloxacin and acyclovir; and 2) the precision component assessed as the standard deviation of samples analyzed in repeatability conditions (Separovic et al, 2018;Separovic et al, 2023;Milde et al, 2020).…”
Section: Measurement Uncertainty Evaluationmentioning
confidence: 99%